日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Target Identification with Live-Cell Photoaffinity Labeling and Mechanism of Action Elucidation of ARN23765, a Highly Potent CFTR Corrector.

利用活细胞光亲和标记进行靶标鉴定和高效 CFTR 校正剂 ARN23765 的作用机制阐明

Romeo Elisa, Saccoliti Francesco, Ocello Riccardo, Andonaia Angela, Allegretta Caterina, Pastorino Cristina, Pedemonte Nicoletta, Falchi Federico, Laselva Onofrio, Bandiera Tiziano, Bertozzi Fabio

Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors

通过分子靶向去泛素化酶USP14来克服卵巢癌的顺铂耐药性并鉴定新型抑制剂

Corno, Cristina; Russo, Debora; Pignotti, Francesco; De Giorgi, Francesca; Penna, Ilaria; Saccoliti, Francesco; Costantino, Matteo; Mirra, Luca; Pettinari, Pietro; Carenini, Nives; Corna, Elisabetta; Perta, Nunzio; Ciniselli, Chiara M; Pratesi, Pietro; Scarpelli, Rita; Bertozzi, Fabio; Verderio, Paolo; Beretta, Giovanni L; Di Muccio, Giovanni; Di Marino, Daniele; Bandiera, Tiziano; Perego, Paola

Editorial: Protein-Protein Interactions: Drug Discovery for the Future

社论:蛋白质-蛋白质相互作用:面向未来的药物发现

Rapposelli, Simona; Gaudio, Eugenio; Bertozzi, Fabio; Gul, Sheraz

A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators

欧洲对囊性纤维化的监管视角:当前治疗方法、药物研发趋势以及CFTR调节剂的转化挑战

Ponzano, Stefano; Nigrelli, Giulia; Fregonese, Laura; Eichler, Irmgard; Bertozzi, Fabio; Bandiera, Tiziano; Galietta, Luis J V; Papaluca, Marisa

A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation

一种强效全身活性N-酰基乙醇胺酸酰胺酶抑制剂,可抑制炎症和人巨噬细胞活化

Ribeiro, Alison; Pontis, Silvia; Mengatto, Luisa; Armirotti, Andrea; Chiurchiù, Valerio; Capurro, Valeria; Fiasella, Annalisa; Nuzzi, Andrea; Romeo, Elisa; Moreno-Sanz, Guillermo; Maccarrone, Mauro; Reggiani, Angelo; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele

3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration

3-氨基氮杂环丁酮-2-酮衍生物作为N-酰基乙醇胺酸酰胺酶(NAAA)抑制剂,适用于全身给药

Fiasella, Annalisa; Nuzzi, Andrea; Summa, Maria; Armirotti, Andrea; Tarozzo, Glauco; Tarzia, Giorgio; Mor, Marco; Bertozzi, Fabio; Bandiera, Tiziano; Piomelli, Daniele